Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsung-Hui Hu

Showing results (81-90 of 364) with videos related to

Pageof 37
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 1, 2020
Associations of HBV Genotype B vs C Infection With Relapse After Cessation of Entecavir or Tenofovir TherapyShao-Ming Chiu, Yuan-Hung Kuo, Jing-Houng Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 16, 2015
Association Between Level of Hepatitis B Surface Antigen and Relapse After Entecavir Therapy for Chronic Hepatitis B Virus InfectionChien-Hung Chen, Chao-Hung Hung, Tsung-Hui Hu, et al.
BMC Gastroenterology|July 27, 2016
Peripheral blood toll-like receptor 4 correlates with rapid virological response to pegylated-interferon and ribavirin therapy in hepatitis C genotype 1 patientsChuan-Mo Lee, Tsung-Hui Hu, Sheng-Nan Lu, et al.
Annals of Hematology|August 22, 2009
Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patientsSung-Nan Pei, Chien-Hung Chen, Chuan-Mo Lee, et al.
Journal of Hepatology|May 7, 2014
The role of hepatitis B surface antigen quantification in predicting HBsAg loss and HBV relapse after discontinuation of lamivudine treatmentChien-Hung Chen, Sheng-Nan Lu, Chao-Hung Hung, et al.
Digestive Diseases and Sciences|July 9, 2021
Predictors of Virological Suppression After Clinical Relapse in Patients Who Discontinued Entecavir or TenofovirHsin-Wei Fang, Yi-Hao Yen, Chao-Hung Hung, et al.
The Journal of Infectious Diseases|December 11, 2021
Earlier and Higher Rate of Hepatitis B Virus Relapse After Discontinuing Tenofovir Versus Entecavir in Hepatitis B e Antigen-Positive PatientsChien-Hung Chen, Cheng-Yuan Peng, Yuan-Hung Kuo, et al.
Journal of Pain and Symptom Management|December 8, 2024
Bereaved Family Quality of Life Varies With Comorbid Psychological Distress and ICU-Care QualityFur-Hsing Wen, Holly G Prigerson, Li-Pang Chuang, et al.
Critical Care (London, England)|November 11, 2024
Factors of prolonged-grief-disorder symptom trajectories for ICU bereaved family surrogatesFur-Hsing Wen, Holly G Prigerson, Li-Pang Chuang, et al.
Viruses|December 23, 2022
HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-ViralKuo-Chin Chang, Ming-Tsung Lin, Jing-Houng Wang, et al.
Pageof 37

Showing results (81-90 of 364) with videos related to

Sort By:
Pageof 37
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 1, 2020
Associations of HBV Genotype B vs C Infection With Relapse After Cessation of Entecavir or Tenofovir TherapyShao-Ming Chiu, Yuan-Hung Kuo, Jing-Houng Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 16, 2015
Association Between Level of Hepatitis B Surface Antigen and Relapse After Entecavir Therapy for Chronic Hepatitis B Virus InfectionChien-Hung Chen, Chao-Hung Hung, Tsung-Hui Hu, et al.
BMC Gastroenterology|July 27, 2016
Peripheral blood toll-like receptor 4 correlates with rapid virological response to pegylated-interferon and ribavirin therapy in hepatitis C genotype 1 patientsChuan-Mo Lee, Tsung-Hui Hu, Sheng-Nan Lu, et al.
Annals of Hematology|August 22, 2009
Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patientsSung-Nan Pei, Chien-Hung Chen, Chuan-Mo Lee, et al.
Journal of Hepatology|May 7, 2014
The role of hepatitis B surface antigen quantification in predicting HBsAg loss and HBV relapse after discontinuation of lamivudine treatmentChien-Hung Chen, Sheng-Nan Lu, Chao-Hung Hung, et al.
Digestive Diseases and Sciences|July 9, 2021
Predictors of Virological Suppression After Clinical Relapse in Patients Who Discontinued Entecavir or TenofovirHsin-Wei Fang, Yi-Hao Yen, Chao-Hung Hung, et al.
The Journal of Infectious Diseases|December 11, 2021
Earlier and Higher Rate of Hepatitis B Virus Relapse After Discontinuing Tenofovir Versus Entecavir in Hepatitis B e Antigen-Positive PatientsChien-Hung Chen, Cheng-Yuan Peng, Yuan-Hung Kuo, et al.
Journal of Pain and Symptom Management|December 8, 2024
Bereaved Family Quality of Life Varies With Comorbid Psychological Distress and ICU-Care QualityFur-Hsing Wen, Holly G Prigerson, Li-Pang Chuang, et al.
Critical Care (London, England)|November 11, 2024
Factors of prolonged-grief-disorder symptom trajectories for ICU bereaved family surrogatesFur-Hsing Wen, Holly G Prigerson, Li-Pang Chuang, et al.
Viruses|December 23, 2022
HBcrAg Predicts Hepatocellular Carcinoma Development in Chronic B Hepatitis Related Liver Cirrhosis Patients Undergoing Long-Term Effective Anti-ViralKuo-Chin Chang, Ming-Tsung Lin, Jing-Houng Wang, et al.
Pageof 37